Mysimba for weight loss – what is this drug?
Mysimba is a medication used for weight management in adults who have a body mass index (BMI) of 30 or more, or a BMI of 27 or more with weight-related conditions. It contains a combination of two active ingredients: bupropion and naltrexone. Bupropion is an antidepressant and smoking cessation aid, while naltrexone is primarily used to manage alcohol and opioid dependence. Together, they work to suppress appetite and reduce cravings, helping individuals achieve sustainable weight loss.
How does bupropion + naltrexone work?
Bupropion + naltrexone work synergistically to promote weight loss. Bupropion acts on certain brain chemicals to decrease appetite and enhance the feeling of fullness. It also increases the body’s energy expenditure. Naltrexone, on the other hand, helps to reduce food cravings by blocking certain receptors involved in addiction and reward pathways. The combination of these two medications helps to control food intake and support weight management efforts.
Bupropion + naltrexone for weight loss – indications
Bupropion + naltrexone is indicated for use in adults with a body mass index (BMI) of 30 or greater, or in those with a BMI of 27 or greater with at least one weight-related condition (e.g., high blood pressure, type 2 diabetes, or high cholesterol). This medication should be used as part of a comprehensive weight management program that includes a reduced-calorie diet and increased physical activity.
Bupropion + naltrexone for weight loss – dosage
The recommended starting dose of bupropion + naltrexone is one tablet containing 8 mg of naltrexone and 90 mg of bupropion, taken orally once per day. The dose is gradually increased over time to reach a maintenance dose of two tablets (16 mg of naltrexone and 180 mg of bupropion) taken in the morning and evening. It is important to follow the prescribed dosage and instructions provided by your healthcare professional.
The effectiveness of Mysimba. How much weight can you lose?
The effectiveness of Mysimba varies from person to person. Clinical studies have shown that,